463
Views
21
CrossRef citations to date
0
Altmetric
Review

Minimal mesangial lupus nephritis: a systematic review

, &
Pages 181-189 | Received 11 Jul 2009, Accepted 02 Nov 2009, Published online: 18 Feb 2010

References

  • Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004;15:241–50.
  • Appel GB, Silva FG, Pirani C. Renal involvement in systemic lupus erythematosus (SLE): a study of 56 patients emphasizing histologic classification. Medicine 1978;75:371–410.
  • Churg J, Sobin LH. Renal disease: classification and atlas of glomerular disease. Tokyo: Igaku-Shoin, 1982.
  • Al Arfaj AS, Khalil N, Al Saleh S. Lupus nephritis among 624 cases of systemic lupus erythematosus in Riyadh, Saudi Arabia. Rheumatol Int 2009;29:1057–67.
  • Brugos B, Kiss E, Szodoray P, Szegedi G, Zeher M. Retrospective analysis of patients with lupus nephritis: data from a large clinical immunological center in Hungary. Scand J Immunol 2006;64:433–7.
  • Mok CC, Wong RW, Lau CS. Lupus nephritis in Southern Chinese patients: clinicopathologic findings and long-term outcome. Am J Kidney Dis 1999;34:315–23.
  • Bono L, Cameron JS, Hicks JA. The very long-term prognosis and complications of lupus nephritis and its treatment. Q J Med 1999;92:211–18.
  • Huong DL, Papo T, Beaufils H, Wechsler B, Bletry O, Baumelou A, Renal involvement in systemic lupus erythematosus. A study of 180 patients from a single center. Medicine (Baltimore) 1999;78:148–66.
  • Neumann K, Wallace DJ, Azen C, Nessim S, Fichman M, Metzger AL, Lupus in the 1980s: III. Influence of clinical variables, biopsy, and treatment on the outcome in 150 patients with lupus nephritis seen at a single center. Semin Arthritis Rheum 1995;25:47–55.
  • Shayakul C, Ong-aj-yooth L, Chirawong P, Nimmannit S, Parichatikanond P, Laohapand T, Lupus nephritis in Thailand: clinicopathologic findings and outcome in 569 patients. Am J Kidney Dis 1995;26:300–7.
  • Donadio JV Jr, Hart GM, Bergstralh EJ, Holley KE. Prognostic determinants in lupus nephritis: a long-term clinicopathologic study. Lupus 1995;4:109–15.
  • Lupus nephritis: prognostic factors and probability of maintaining life-supporting renal function 10 years after the diagnosis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL). Am J Kidney Dis 1992;19:473–9.
  • Leaker B, Fairley KF, Dowling J, Kincaid-Smith P. Lupus nephritis: clinical and pathological correlation. Q J Med 1987;62:163–79.
  • Parichatikanond P, Francis ND, Malasit P, Laohapand T, Nimmannit S, Singchoovong L, Lupus nephritis: clinicopathological study of 162 cases in Thailand. J Clin Pathol 1986;39:160–6.
  • Banfi G, Mazzucco G, Barbiano di Belgiojoso G, Bestetti Bosisio M, Stratta P, Confalonieri R, Morphological parameters in lupus nephritis: their relevance for classification and relationship with clinical and histological findings and outcome. Q J Med 1985;55:153–68.
  • Deji N, Sugimoto T, Kanasaki M, Aoyama M, Tanaka Y, Sakaguchi M, Emerging minimal-change nephrotic syndrome in a patient with chronic mesangial proliferative lupus nephritis. Intern Med 2007;46:991–5.
  • Wang YT, Chou HH, Chen FF, Chen MJ, Chiou YY. A case of minimal-change nephrotic syndrome in pediatric lupus erythematosus: just a coincidence? Lupus 2006;15:244–7.
  • Horino T, Takao T, Morita T, Ito H, Hashimoto K. Minimal change nephrotic syndrome associated with systemic lupus erythematosus. Nephrol Dial Transplant 2006;21:230.
  • Dube GK, Markowitz GS, Radhakrishnan J, Appel GB, D'Agati VD. Minimal change disease in systemic lupus erythematosus. Clin Nephrol 2002;57:120–6.
  • Hertig A, Droz D, Lesavre P, Grünfeld JP, Rieu P. SLE and idiopathic nephrotic syndrome: coincidence or not? Am J Kidney Dis 2002;40:1179–84.
  • Perakis C, Arvanitis A, Sotsiou F, Emmanouel DS. Nephrotic syndrome caused by minimal-change disease in a patient with focal proliferative SLE nephritis (WHO III) in remission. Nephrol Dial Transplant 1998;13:467–70.
  • Guery B, Martinez F, Beaufils H, Deray G. Minimal-change nephropathy associated with systemic lupus erythematosus. Nephrol Dial Transplant 1997;12:2030–1.
  • Nishihara G, Nakamoto M, Yasunaga C, Takeda K, Matsuo K, Urabe M, Systemic lupus erythematosus in a patient with remitting minimal change nephrotic syndrome. Clin Nephrol 1997;48:327–30.
  • Makino H, Haramoto T, Shikata K, Ogura T, Ota Z. Minimal-change nephrotic syndrome associated with systemic lupus erythematosus. Am J Nephrol 1995;15:439–41.
  • Vachvanichsanong P, Dissaneewate P, McNeil E. Diffuse proliferative glomerulonephritis does not determine the worst outcome in childhood onset lupus nephritis: a 23-year experience in a single centre. Nephrol Dial Transplant 2009;24:2729–34.
  • Hari P, Bagga A, Mahajan P, Dinda A. Outcome of lupus nephritis in Indian children. Lupus 2009;18:348–54.
  • Ataei N, Haydarpour M, Madani A, Esfahani ST, Hajizadeh N, Moradinejad MH, Outcome of lupus nephritis in Iranian children: prognostic significance of certain features. Pediatr Nephrol 2008;23:749–55.
  • Lee BS, Cho HY, Kim EJ, Kang HG, Ha IS, Cheong HI, Clinical outcomes of childhood lupus nephritis: a single center's experience. Pediatr Nephrol 2007;22:222–31.
  • Wong SN, Tse KC, Lee TL, Lee KW, Chim S, Lee KP, Lupus nephritis in Chinese children – a territory-wide cohort study in Hong Kong. Pediatr Nephrol 2006;21:1104–12.
  • Bogdanovic R, Nikolic V, Pasic S, Dimitrijevic J, Lipkovska-Markovic J, Eric-Marinkovic J, Lupus nephritis in childhood: a review of 53 patients followed at a single center. Pediatr Nephrol 2004;19:36–44.
  • Hagelberg S, Lee Y, Bargman J, Mah G, Schneider R, Laskin C, Long-term follow-up of childhood lupus nephritis. J Rheumatol 2002;29:2635–42.
  • Baqi N, Moazami S, Singh A, Ahmad H, Balachandra S, Tejani A. Lupus nephritis in children: a longitudinal study of prognostic factors and therapy. J Am Soc Nephrol 1996;7:924–9.
  • Yang LY, Chen WP, Lin CY. Lupus nephritis in children – a review of 167 patients. Pediatrics 1994;94:335–40.
  • Mok CC, Tong KH, To CH, Siu YP, Ho LY, Au TC. Risk and predictors of arterial thrombosis in lupus and non-lupus primary glomerulonephritis: a comparative study. Medicine (Baltimore) 2007;86:203–9.
  • Mathieson PW. Minimal change nephropathy and focal segmental glomerulosclerosis. Semin Immunopathol 2007;29:415–26.
  • Chang JH, Kim DK, Kim HW, Park SY, Yoo TH, Kim BS, Changing prevalence of glomerular diseases in Korean adults: a review of 20 years of experience. Nephrol Dial Transplant 2009;24:2406–10.
  • Glassock RJ. Secondary minimal change disease. Nephrol Dial Transplant 2003;18(Suppl 6):vi52–8.
  • Grimbert P, Audard V, Remy P, Lang P, Sahali D. Recent approaches to the pathogenesis of minimal-change nephrotic syndrome. Nephrol Dial Transplant 2003;18:245–8.
  • Araya CE, Wasserfall CH, Brusko TM, Mu W, Segal MS, Johnson RJ, A case of unfulfilled expectations. Cytokines in idiopathic minimal lesion nephrotic syndrome. Pediatr Nephrol 2006;21:603–10.
  • Smith JD, Hayslett JP. Reversible renal failure in the nephrotic syndrome. Am J Kidney Dis 1992;19:201–13.
  • Vande Walle J, Mauel R, Raes A, Vandekerckhove K, Donckerwolcke R. ARF in children with minimal change nephrotic syndrome may be related to functional changes of the glomerular basal membrane. Am J Kidney Dis 2004;43:399–404.
  • Furuya R, Kumagai H, Ikegaya N, Kobayashi S, Kimura M, Hishida A, Reversible acute renal failure in idiopathic nephrotic syndrome. Intern Med 1993;32:31–5.
  • Han TS, Schwartz MM, Lewis EJ. Association of glomerular podocytopathy and nephrotic proteinuria in mesangial lupus nephritis. Lupus 2006;15:71–5.
  • Kraft SW, Schwartz MM, Korbet SM, Lewis EJ. Glomerular podocytopathy in patients with systemic lupus erythematosus. J Am Soc Nephrol 2005;16:175–9.
  • Palmer SC, Nand K, Strippoli GF. Interventions for minimal change disease in adults with nephrotic syndrome. Cochrane Database Syst Rev 2008;(1):CD001537.
  • Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet 2003;362:629–39.
  • Sepe V, Libetta C, Giuliano MG, Adamo G, Dal Canton A. Mycophenolate mofetil in primary glomerulopathies. Kidney Int 2008;73:154–62.
  • Yang T, Nast CC, Vo A, Jordan SC. Rapid remission of steroid and mycophenolate mofetil (mmf)-resistant minimal change nephrotic syndrome after rituximab therapy. Nephrol Dial Transplant 2008;23:377–80.
  • Mok CC, Wong RW, Lai KN. Treatment of severe proliferative lupus nephritis: the current state. Ann Rheum Dis 2003;62:799–804.
  • Mok CC. Membranous nephropathy in systemic lupus erythematosus: a therapeutic enigma. Nat Rev Nephrol 2009;5:212–20.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.